Biovir Laboratories, Inc.
Country not established
- Devices
- 1
What Biovir Laboratories, Inc. makes
Biovir Laboratories, Inc. manufactures direct fluorescent antibody reagents specifically designed for detecting *Giardia* parasites in clinical samples. These reagents are intended for use in laboratory settings to identify infectious organisms via fluorescence microscopy.
The company’s products are classified as Class II medical devices under FDA regulations and are authorised through the 510(k) clearance process. The portfolio is listed in the FDA’s 510(k) database, and the manufacturer is based in the United States.
Catalogue
Direct Fluorescent Antibody Reagent For Giardia Ref K900604
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Biovir Laboratories, Inc. have in the registry?
The registry currently lists 1 device for Biovir Laboratories, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Biovir Laboratories, Inc.'s devices?
Among its 1 most recently registered device, Biovir Laboratories, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Biovir Laboratories, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Biovir Laboratories, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Biovir Laboratories, Inc. in the registry?
The most recently registered devices listed for Biovir Laboratories, Inc. include DIRECT FLUORESCENT ANTIBODY REAGENT FOR GIARDIA.